Laser Ablation a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia
Recruiting
Observational Study
Benign Prostatic Hyperplasia (BPH)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 40 and older
- Sex
- Male
- Study type
- Observational
- Participants needed
- 20 (estimated)
- Sponsor
- The Cleveland Clinic · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Benign prostatic hyperplasia (BPH) is a common condition affecting aging men, often leading to lower urinary tract symptoms (LUTS). While Minimally Invasive Surgical Therapies (MIST) procedures offer less invasive alternatives to traditional surgery, some patients experience symptom recurrence or require further intervention due to lack of adequate relief of obstruction. Treatment of persistent ob…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Men \> 40 years old
* History of Minimally invasive BPH procedure within the last 5 years.
* IPSS \>= 12
* Prostate Volume 30 - 80 gr as assessed by CT, MRI or TRUS.
* PSA \<4 or for patients with PSA 4-10 evaluation has been performed to rule out prostate cancer using biopsy,…
Contacts
No contact information available.